Insulet Corp

詳細情報 Insulet Corp 企業名

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

企業情報

企業コードPODD

会社名Insulet Corp

上場日May 15, 2007

設立日2000

最高経営責任者「CEO」Ms. Ashley Mcevoy

従業員数3900

証券種類Ordinary Share

決算期末May 15

本社所在地100 Nagog Park

都市ACTON

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号01720-3440

電話番号19786007000

ウェブサイトhttps://www.omnipod.com

企業コードPODD

上場日May 15, 2007

設立日2000

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

16.23K

+5.03%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

--

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238.50K%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Mr. Prem Singh

Senior Vice President - Global Operations

4.25K

-20.11%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

+24.38%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

16.23K

+5.03%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

--

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238.50K%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

事業別USD

会社名

収益

比率

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

地域別USD

会社名

収益

比率

United States

1.55B

74.73%

All Other

523.40M

25.27%

事業別

地域別

事業別USD

会社名

収益

比率

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

12.28%

Fidelity Management & Research Company LLC

10.13%

Capital Research Global Investors

8.64%

BlackRock Institutional Trust Company, N.A.

6.20%

State Street Global Advisors (US)

4.30%

Other

58.46%

株主統計

比率

The Vanguard Group, Inc.

12.28%

Fidelity Management & Research Company LLC

10.13%

Capital Research Global Investors

8.64%

BlackRock Institutional Trust Company, N.A.

6.20%

State Street Global Advisors (US)

4.30%

Other

58.46%

種類

株主統計

比率

Investment Advisor

55.58%

Investment Advisor/Hedge Fund

36.15%

Hedge Fund

3.40%

Research Firm

2.90%

Pension Fund

1.66%

Sovereign Wealth Fund

1.45%

Bank and Trust

1.38%

Individual Investor

0.29%

Private Equity

0.10%

機関投資家保有株

更新時刻: Mon, Jan 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1519

73.36M

104.26%

-4.82M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

2023Q1

1206

74.71M

107.20%

-300.49K

2022Q4

1126

71.74M

103.30%

-3.89M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

8.46M

12.05%

+16.65K

+0.20%

Dec 31, 2024

Fidelity Management & Research Company LLC

7.08M

10.08%

-246.09K

-3.36%

Dec 31, 2024

Capital Research Global Investors

7.45M

10.6%

-326.10K

-4.20%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

4.25M

6.05%

+74.08K

+1.77%

Dec 31, 2024

State Street Global Advisors (US)

2.97M

4.24%

+59.55K

+2.04%

Dec 31, 2024

Baillie Gifford & Co.

2.36M

3.35%

+79.98K

+3.51%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.78M

2.53%

+40.57K

+2.33%

Dec 31, 2024

ClearBridge Investments, LLC

1.41M

2%

-62.73K

-4.27%

Dec 31, 2024

Fidelity International

1.43M

2.04%

-9.70K

-0.67%

Dec 31, 2024

American Century Investment Management, Inc.

854.87K

1.22%

-3.60K

-0.42%

Dec 31, 2024

詳細を見る

306.230USD

Insulet Corp

306.230

概要

企業名